Prevention strategies for blood‐borne viruses—in the Era of vaccines, direct acting antivirals and antiretroviral therapy

Blood‐borne viruses, such as hepatitis B virus, hepatitis C virus, human immunodeficiency virus, and the facultative blood‐borne hepatitis E virus, are considered a major public health problem given that they are accountable for millions of deaths each year. Treatment options, including effective va...

Descripción completa

Detalles Bibliográficos
Autores principales: Pfaender, Stephanie, von Hahn, Thomas, Steinmann, Joerg, Ciesek, Sandra, Steinmann, Eike
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5084801/
https://www.ncbi.nlm.nih.gov/pubmed/27185010
http://dx.doi.org/10.1002/rmv.1890
_version_ 1782463458844868608
author Pfaender, Stephanie
von Hahn, Thomas
Steinmann, Joerg
Ciesek, Sandra
Steinmann, Eike
author_facet Pfaender, Stephanie
von Hahn, Thomas
Steinmann, Joerg
Ciesek, Sandra
Steinmann, Eike
author_sort Pfaender, Stephanie
collection PubMed
description Blood‐borne viruses, such as hepatitis B virus, hepatitis C virus, human immunodeficiency virus, and the facultative blood‐borne hepatitis E virus, are considered a major public health problem given that they are accountable for millions of deaths each year. Treatment options, including effective vaccine design, development of antiviral strategies and the implementation of antiretroviral therapy have improved substantially over the last couple of years and contribute to successful treatment and prevention of these infectious diseases. In this review, we summarise the current knowledge and concepts in prevention of transmission of these blood‐borne viruses.
format Online
Article
Text
id pubmed-5084801
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-50848012016-11-09 Prevention strategies for blood‐borne viruses—in the Era of vaccines, direct acting antivirals and antiretroviral therapy Pfaender, Stephanie von Hahn, Thomas Steinmann, Joerg Ciesek, Sandra Steinmann, Eike Rev Med Virol Reviews Blood‐borne viruses, such as hepatitis B virus, hepatitis C virus, human immunodeficiency virus, and the facultative blood‐borne hepatitis E virus, are considered a major public health problem given that they are accountable for millions of deaths each year. Treatment options, including effective vaccine design, development of antiviral strategies and the implementation of antiretroviral therapy have improved substantially over the last couple of years and contribute to successful treatment and prevention of these infectious diseases. In this review, we summarise the current knowledge and concepts in prevention of transmission of these blood‐borne viruses. John Wiley and Sons Inc. 2016-05-17 2016-09 /pmc/articles/PMC5084801/ /pubmed/27185010 http://dx.doi.org/10.1002/rmv.1890 Text en © 2016 The Authors Reviews in Medical Virology Published by John Wiley & Sons Ltd This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial‐NoDerivs (http://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Reviews
Pfaender, Stephanie
von Hahn, Thomas
Steinmann, Joerg
Ciesek, Sandra
Steinmann, Eike
Prevention strategies for blood‐borne viruses—in the Era of vaccines, direct acting antivirals and antiretroviral therapy
title Prevention strategies for blood‐borne viruses—in the Era of vaccines, direct acting antivirals and antiretroviral therapy
title_full Prevention strategies for blood‐borne viruses—in the Era of vaccines, direct acting antivirals and antiretroviral therapy
title_fullStr Prevention strategies for blood‐borne viruses—in the Era of vaccines, direct acting antivirals and antiretroviral therapy
title_full_unstemmed Prevention strategies for blood‐borne viruses—in the Era of vaccines, direct acting antivirals and antiretroviral therapy
title_short Prevention strategies for blood‐borne viruses—in the Era of vaccines, direct acting antivirals and antiretroviral therapy
title_sort prevention strategies for blood‐borne viruses—in the era of vaccines, direct acting antivirals and antiretroviral therapy
topic Reviews
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5084801/
https://www.ncbi.nlm.nih.gov/pubmed/27185010
http://dx.doi.org/10.1002/rmv.1890
work_keys_str_mv AT pfaenderstephanie preventionstrategiesforbloodbornevirusesintheeraofvaccinesdirectactingantiviralsandantiretroviraltherapy
AT vonhahnthomas preventionstrategiesforbloodbornevirusesintheeraofvaccinesdirectactingantiviralsandantiretroviraltherapy
AT steinmannjoerg preventionstrategiesforbloodbornevirusesintheeraofvaccinesdirectactingantiviralsandantiretroviraltherapy
AT cieseksandra preventionstrategiesforbloodbornevirusesintheeraofvaccinesdirectactingantiviralsandantiretroviraltherapy
AT steinmanneike preventionstrategiesforbloodbornevirusesintheeraofvaccinesdirectactingantiviralsandantiretroviraltherapy

Ejemplares similares